Market revenue in 2023 | USD 341.6 million |
Market revenue in 2030 | USD 459.4 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Chagas disease |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 9.48% in 2023. Horizon Databook has segmented the China neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing healthcare spending, growing population, and high prevalence of NTDs are among factors expected to fuel market growth. According to an NCBI report, in 2017, the number of schistosomiasis cases was around 37,600, the number of dengue cases was about 6,000, and that of other NTDs, such as leprosy, leishmaniasis, and rabies, was 600 or less in China.
China has the world’s largest population, creating a larger pool of patients with NTDs. In addition, presence of large geriatric population is driving the market growth. According to PRB report, the geriatric population in China was approximately 1,398 million in 2020. Individuals aged 60 & above are highly susceptible to NTDs.
Horizon Databook provides a detailed overview of country-level data and insights on the China neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into China neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account